This indefinite delivery contract (IDC) was awarded by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration, Veterans Integrated Service Network 17, to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The $1,424,520 single-award contract covers the procurement of Cepheid's XPRESS COV-2/FLU/RSV PLUS and XPRESS COVID PLUS testing supplies for the North Texas VA Health Care System and Pathology and Laboratory Medicine Service located in Dallas, Texas. The contract includes a base period and two option periods, with a total performance period extending through March 2028.
The VA determined Cepheid to be the sole source capable of providing these specialized testing materials, which are FDA-approved and meet CLIA and CAP requirements. Under this IDC, Cepheid will supply the testing kits, educational materials, and necessary support services on an as-needed basis, without a predetermined delivery schedule. This procurement leverages the VA's statutory authority to award a sole source contract when only one responsible source can meet the agency's requirements. While the initial award is sole source to Cepheid, the VA has invited capable sources to submit information demonstrating their ability to provide comparable solutions.
Generated 3/14/25, 9:49 AM